Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Kilitch Drugs(I) Ltd.	Income Statement

NSE: KILITCHBE BSE: 524500ISIN: INE729D01010INDUSTRY: Pharmaceuticals

BSE

Rs 443.05

Open: 443.05

Today's Range 443.05

445.00

NSE
Rs 444.00
-1.00 ( -0.23 %)

-1.95 ( -0.44 %)

Prev Close: 445.00

52 Week Range 278.16

490.00

You can view the Income Statement for the last 5 years.

Market Cap. (Rs.)	776.15 Cr.	P/BV	3.08	Book Value (Rs.)	144.30
52 Week High/Low (Rs.)	500/305	FV/ML	10/1	P/E(X)	29.49
Bookclosure	15/07/2025	EPS (Rs.)	15.06	Div Yield (%)	0.00

(Rs. in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	198.32	153.61	138.86	112.96	68.13
Other Operating Revenues	0.00	0.77	0.74	1.28	0.39
Total Operating Revenues	198.32	154.37	139.60	114.23	68.52

Other Income	11.16	4.48	2.92	2.91	2.67
Total Revenue	209.48	158.85	142.52	117.14	71.19

EXPENSES
Cost Of Materials Consumed	105.75	79.08	74.53	65.48	36.22
Changes In Inventories Of FG,WIP And Stock-In Trade	-1.17	-0.12	0.23	-0.05	1.09
Employee Benefit Expenses	11.32	10.01	11.73	6.18	5.24
Finance Costs	5.04	5.93	4.92	1.20	0.75
Depreciation And Amortisation Expenses	3.11	3.35	3.55	2.47	1.99
Other Expenses	51.33	41.24	35.54	32.25	20.78
Total Expenses	175.39	139.50	130.50	107.53	66.07

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	34.09	19.35	12.01	9.61	5.12

Profit/Loss Before Tax	34.09	19.35	12.01	9.61	5.12

Tax Expenses-Continued Operations
Current Tax	9.53	6.37	4.20	3.63	1.67
Deferred Tax	0.00	-0.59	-0.47	-0.23	-0.31
Total Tax Expenses	9.53	5.78	3.73	3.40	1.35
Profit/Loss After Tax And Before ExtraOrdinary Items	24.56	13.58	8.28	6.21	3.77

Profit/Loss From Continuing Operations	24.56	13.58	8.28	6.21	3.77

Profit/Loss For The Period	24.56	13.58	8.28	6.21	3.77

Minority Interest	1.76	1.03	2.17	1.15	-0.10
Consolidated Profit/Loss After MI And Associates	26.32	14.60	10.45	7.37	3.67

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	15.27	9.17	6.71	4.73	2.37
Diluted EPS (Rs.)	0.00	9.17	6.71	4.73	2.37

Market

Derivatives

Mutual Fund

IPO

Quick Links

Kilitch Drugs(I) Ltd.

Income Statement